white → yellow2 → brown2
4-AcO-DMT
4-Acetoxy-N,N-dimethyltryptamine
Psilacetin, O-Acetylpsilocin, Synthetic mushrooms
4-AcO-DMT is a synthetic psychedelic of the tryptamine class, first synthesized by Albert Hofmann and Franz Troxler in 1963 during a chemical investigation into psilocin analogs.1 It is the acetylated form of psilocin and is widely believed to act as a prodrug for it, much like psilocybin.2 Its effects are frequently described as nearly indistinguishable from those of psilocybin mushrooms3, though sometimes characterized as warmer or more euphoric. It has a limited history of human use.
Dosage & Duration
Dosage
Doses are population estimates that vary widely between individuals.
Threshold~5 mg
Light5-15 mg
Moderate15-25 mg
Strong25-40 mg
Heavy40+ mg
Duration
Onset20-40 minutes
Come Up30-75 minutes
Peak2-3.5 hours
Offset1-2 hours
After Effects2-4 hours
Total4-7 hours
Subjective Effects
Effects vary widely by individual, dose, and context.
Physical
The physical effects of 4-AcO-DMT can be broken down into two components all of which progressively intensify proportional to dosage.
Cognitive
The head space of 4-AcO-DMT is described by many as extremely relaxing, profound and stoning in its style when compared to other commonly used psychedelics such as LSD or 2C-B which tend to be energetic and stimulating. It contains a large number of psychedelic typical and unique cognitive effects.
Enhancement of current mind stateConnectivity of thoughtFeelings of fascination, importance and aweTime distortionOutrospectionDeja-VuRemoval of cultural filterFeelings of predeterminismConceptual thinkingDirect communication with the subconsciousEgo suppression, loss and deathFeelings of interdependent oppositesDelusionsStates of unity and interconnectedness
Visual
Enhancements
4-AcO-DMT presents a full and complete array of possible visual enhancements.
Geometry
The visual geometry that is present throughout this trip can be described as more similar in appearance to that of ayahuasca and 2C-E than LSD. It can be comprehensively described as structured in its organization, organic in geometric style, intricate in complexity, large in size, fast and smooth in motion, colourful in scheme, glossy in colour, blurred in its edges and rounded in its corners. They have a very 'natural' feel to them and at higher dosages are significantly more likely to result in states of Level 7B visual geometry over Level 7A.
Hallucinatory States
4-AcO-DMT and its various other forms produce a full range of high level hallucinatory states in a fashion that is more consistent and reproducible than that of many other commonly used psychedelics.
Auditory
The auditory effects of 4-AcO-DMT are common in their occurrence and exhibit a full range of effects.
Pharmacology
Pharmacodynamics
4-AcO-DMT directly activates human 5-HT2A, 5-HT2B, and 5-HT2C receptors in a Gq-mediated calcium-flux assay; at 5-HT2A it is less potent than psilocin and produces 79.2% of the serotonin maximum.4
Its mouse head-twitch potency is similar to that of psilocin despite this weaker receptor-level potency, which is consistent with deacetylation to psilocin in vivo, but those experiments do not determine how much intact 4-AcO-DMT contributes to effects in humans.4
Pharmacokinetics
After intraperitoneal administration to mice, 4-AcO-DMT fumarate produced about 70% of the total peripheral psilocin exposure produced by an equimolar psilocybin dose; psilocin concentrations were 10–25% lower at 15 minutes, and the approximately 30-minute psilocin half-life did not differ by precursor.5 In an ex-vivo human-plasma stability assay, almost no acetyl ester remained at the first five-minute sample.6 A separate simulated gastrointestinal experiment predicted less than 0.1% of the prodrug remaining after five minutes, but only after extrapolation to an assumed physiological esterase activity; it was not a direct measurement in a dosed human.6 Taken together, these studies support rapid conversion to psilocin but do not provide clinical human pharmacokinetic parameters for 4-AcO-DMT.56
Dangerous
Highest riskThese combinations are considered extremely harmful and should always be avoided. Reactions to these drugs taken in combination are highly unpredictable and have a potential to cause death.
Unsafe
AvoidThere is considerable risk of physical harm when taking these combinations, they should be avoided where possible.
Caution
Use cautionThese combinations are not usually physically harmful, but may produce undesirable effects, such as physical discomfort or overstimulation. Extreme use may cause physical health issues. Synergistic effects may be unpredictable. Care should be taken when choosing to use this combination.
Tolerance
Tolerance timelines are rules of thumb, not exact schedules, and vary widely between individuals and use patterns.
Harm Potential
Addiction & Dependence
Psychological
Extremely Low4-AcO-DMT is considered non-addictive with low potential for abuse. It is not associated with compulsive use, and users commonly report a self-regulating quality where the desire for subsequent use is naturally limited.10
Physical
Extremely LowPhysical dependence is extremely unlikely due to its pharmacological similarity to psilocybin.10
Psychosis Risk
As a psychedelic, 4-AcO-DMT may trigger underlying psychological and mental problems in people predisposed by familial schizophrenia or early-developing mental illness. This risk is mainly associated with predisposed individuals rather than users in general.
Seizure Risk
Seizures are rarely observed and are thought to primarily affect those already predisposed to them11, particularly in physically taxing conditions such as being overheated, dehydrated, undernourished, or fatigued.
History & Culture
Discovery and Initial Research
4-AcO-DMT was first synthesized in 1963 by the Swiss chemists Albert Hofmann and Franz Troxler during systematic investigations into psilocin analogs conducted at Sandoz Laboratories.1 The compound, along with several other psilocin esters, was patented by Sandoz Ltd on…
Trip Reports
Loading related reports
Preparing section content
Still loading. Refresh if this section does not appear.
Legality
International
1961 Single Convention: 4-AcO-DMT is not individually scheduled.
1971 Convention on Psychotropic Substances: 4-AcO-DMT is not individually scheduled.
1988 Convention: 4-AcO-DMT is not listed in precursor Tables I or II.
By Country
United StatesUnscheduled (Federal Analogue Act applies)Citation needed
Not explicitly scheduled under federal law, but possession or sale for human consumption may be prosecuted under the Federal Analogue Act of 1986, as it is considered an analog of the Schedule I substance psilocin.4849 Can be legally possessed for research purposes when labeled 'not for human consumption.' Additionally, 4-AcO-DMT is listed as a Schedule I controlled substance at the state level in several states, including Alabama (since March 18, 2014).50
BelgiumIllegalAnnex IVA, item 5 — tryptamine derivatives (Fig. 5), national generic structural listing
Royal Decree of 6 September 2017 regulating narcotic and psychotropic substances, Annex IVA item 5 (generic tryptamine derivatives), with Articles 3–6 and 61; current Annex IV reference valid from 29 March 2026192021222324
4-AcO-DMT is covered by Belgium's current Annex IVA item 5 generic tryptamine structure: its terminal amine is N,N-dimethyl, its indole ring bears OAc at position 4, and its indole nitrogen is unsubstituted. The Royal Decree's authorization regime makes import, possession and other listed activities prohibited absent prior authorization limited to scientific or medical purposes. AFMPS warns that its consolidated annex is non-official; the Belgian Official Journal and Justel texts control.
Czech RepublicIllegalList No. 4 psychotropic substances (Annex 4)
Nařízení vlády č. 463/2013 Sb., příloha č. 4 (Seznam č. 4 psychotropních látek), current consolidated text effective 25 June 2026; zákon č. 167/1998 Sb., §§ 2(1)(a), 3(1)-(2), 428293031
4-AcO-DMT is expressly named as o-Acetylpsilocin (Psilacetin) in the current Czech Annex 4 schedule. The Act treats listed psychoactive substances as addictive substances, defines handling broadly, requires a handling authorization, and limits Annex 4 substances to restricted research, scientific, and very limited therapeutic purposes specified in that authorization. This supports prohibited rather than unscheduled or merely analogue-covered status; no generic structural analogue rule was needed because the substance is directly listed.
IsraelIllegal (analog/blanket ban)Dangerous Drugs Ordinance First Schedule, Part A, Sign B, item 6: N,N-dimethyltryptamine (DMT), including its isomers and structural derivatives; 4-AcO-DMT covered as a structural derivative
Dangerous Drugs Ordinance [New Version], 5733-1973, sections 1, 6, 7 and 13 and First Schedule Part A Sign B item 6, as amended by the 2017 First-Schedule notice and checked against the 2025 First-Schedule notice3334353637
4-AcO-DMT is not separately named in the inspected Israeli schedule text. PubChem identifies it as 4-acetoxy-N,N-dimethyltryptamine (O-acetylpsilocin), while First Schedule item 6 expressly includes the isomers and structural derivatives of N,N-dimethyltryptamine. On that structural rule, it is covered as a dangerous drug and unauthorized production, possession, use, import/export, dealing and supply are prohibited under sections 6, 7 and 13, subject to the Ordinance's authorization and licence pathways. This is structural-derivative coverage rather than an exact-name listing; a compound-specific Israeli legal opinion could address any edge-case chemistry question.
JapanControlled substanceCitation needed
Designated as a controlled substance effective July 29, 2015, under national drug control legislation.39
SwitzerlandPotentially illegalCitation needed
May be considered illegal under Buchstabe B of Swiss narcotics legislation as an ester analog of psilocin. Legal status is interpreted rather than explicitly scheduled.41
United KingdomIllegalClass A controlled ester
Misuse of Drugs Act 1971, Schedule 2 Part I generic ester control47
The Misuse of Drugs Act 1971 Class A definition covers esters of psilocin; 4-AcO-DMT is controlled through that generic ester provision.
AustraliaSchedule 9Citation needed
BrazilIllegalLista F2 (psychotropic substances; within Lista F, substances whose use is proscribed in Brazil), item 21
Portaria SVS/MS No. 344/1998, Anexo I, Lista F2, item 21 and Adendos 1.1 and 16 (current consolidated text), read with Lei No. 11.343/2006, arts. 1, 2, 31 and 33252627
4-AcO-DMT is expressly and nominally scheduled, not merely captured by a generic analogue or structural-class provision. The entry gives its chemical identity as 4-acetoxi-N,N-dimetiltriptamina; F2 Adendo 1.1 extends control to possible salts and isomers. Adendo 16's up-to-500-mg analytical-standard import/export authorization exemption is a narrow administrative exception and does not make ordinary possession, supply, production or use lawful.
GermanyRestrictedNpSG tryptamine-group control
Neue-psychoaktive-Stoffe-Gesetz, Anlage32
The current NpSG Annex uses a group definition for tryptamine-derived compounds whose structural scope covers 4-AcO-DMT.
ItalyIllegalCitation needed
Prohibited under Italian drug law as an ester of a controlled substance (psilocin). Possession, production, and distribution are criminal offenses.38
SwedenSchedule ICitation needed
Added to the Narcotic Drugs Punishments Act as a Schedule I substance (classified as substances without accepted medical use) on January 25, 2017. Listed as '4-acetoxi-N,N-dimetyltryptamin' in Medical Products Agency regulation HSLF-FS 2017:1.40
TurkeyIllegalLaw No. 2313 controlled narcotic; exact-name listing in the attached unnumbered Gazette annex: 4-AcO-DMT (3-[2-(Dimethylamino)ethyl]-1H-indol-4-yl acetate)
Law No. 2313 on the Control of Narcotic Substances, Article 19; Council of Ministers Decision No. 2013/5742 and its attached unnumbered list, Official Gazette No. 28893 (25 January 2014), expressly listing 4-AcO-DMT by chemical name4243444546
The exact substance is expressly named in the 2013/5742 annex, so this is an exact-listing finding rather than an inference from psilocin, DMT, or a generic analogue rule. The Gazette annex is unnumbered; the '66.' label belongs to the official 2014 Türkiye Uyuşturucu Raporu's numbered reproduction of the list, not to the Gazette annex itself. The current Law 2313 text confirms the Article 19 declaration mechanism, and the 2024 Interior Ministry/EGM report confirms continuing generic NPS classification, but this result does not extend the listing into unsupported substance-specific penalty details.
References
Source Pages
Disregard Everything I Say
Drug Users Bible by Dominic Milton Trott- Drug Users Bible: 4-AcO-DMT
Erowid- Erowid: 4-AcO-DMT Basics
Isomer Design (TiHKAL/PiHKAL)
PsychonautWiki
TripSit Factsheet: 4-AcO-DMT- TripSit Factsheet: 4-AcO-DMT
- TripSit Factsheets
- TripSit Wiki
- TripSit Wiki: 4-AcO-DMT
Wikipedia- Wikipedia: 4-AcO-DMT
Citations
- Hofmann, Albert, & Troxler, Franz. (1963). Esters of indoles. Sandoz AG. https://patents.google.com/patent/US3075992A/en12
- Haden A. Geiger, Madeline G. Wurst, & R. Nathan Daniels. (n.d.). | class = Binding selectivity|Non-selective serotonin receptor agonist ; Serotonin 5-HT2A receptor agonist|Serotonin 5-HT<sub>2A</sub> receptor agonist ; Serotonergic p. https://doi.org/10.1021/acschemneuro.8b001861
- Joseph J. Palamar, & Patricia Acosta. (January 2020). A qualitative descriptive analysis of effects of psychedelic phenethylamines and tryptamines. Human Psychopharmacology, 35(1). https://doi.org/10.1002/hup.2719123
- Adam K. Klein, Muhammad Chatha, Lauren J. Laskowski, Emilie I. Anderson, Simon D. Brandt, Stephen J. Chapman, John D. McCorvy, & Adam L. Halberstadt. (n.d.). However, it is said to produce less nausea and body load than psilocybin-containing mushrooms.<ref name="JonesWagnerHa. https://doi.org/10.1021/acsptsci.0c00176123456789
- Nathan T. Jones, Laura Wagner, Molly C. Pellitteri Hahn, Cameron O. Scarlett, & Cody J. Wenthur. (2024). In vivo validation of psilacetin as a prodrug yielding modestly lower peripheral psilocin exposure than psilocybin. Front Psychiatry, 14. https://doi.org/10.3389/fpsyt.2023.130336512
- Julia Eklund, Ulf Bremberg, Jessica Larsson, Edvard Torkelsson, Johan Wennerberg, Symantha Zandelin, & Luke R. Odell. (March 2025). Synthesis and In Vitro Profiling of Psilocin Derivatives: Improved Stability and Synthetic Properties. J Med Chem, 68(7), 7153–7165. https://doi.org/10.1021/acs.jmedchem.4c02612123
- Tentative identification of in vitro metabolites of O-acetylpsilocin (psilacetin, 4-AcO-DMT) by UHPLC-Q-Orbitrap MS. doi.org (n.d.). https://doi.org/10.1002/dta.325512
- Nichols DE. (2016). Psychedelics. Pharmacological Reviews, 68(2), 264-355. https://doi.org/10.1124/pr.115.01147812
- Halberstadt AL, & Geyer MA. (2011). Multiple receptors contribute to the behavioral effects of indoleamine hallucinogens. Neuropharmacology. https://doi.org/10.1016/j.neuropharm.2011.01.0171
- Johnson MW, Griffiths RR, Hendricks PS, & Henningfield JE. (2018). The Abuse Potential of Medical Psilocybin According to the 8 Factors of the Controlled Substances Act. Neuropharmacology, 142, 143-166. https://doi.org/10.1016/j.neuropharm.2018.05.01212
- Simonsson O, Goldberg SB, Chambers R, Osika W, Long DM, & Hendricks PS. (2022). Prevalence and associations of classic psychedelic-related seizures in a population-based sample. Drug and Alcohol Dependence, 239, Article 109586. https://doi.org/10.1016/j.drugalcdep.2022.1095861
- David E. Nichols. (1999). Improvements to the Synthesis of Psilocybin and a Facile Method for Preparing the O-Acetyl Prodrug of Psilocin. Synthesis, 1999(6), 935–938. https://doi.org/10.1055/s-1999-3490123
- 4-AcO-DMT Is the Most Accessible (and Mysterious) Drug on the Market Right Now. DoubleBlind Mag (24 June 2024). https://doubleblindmag.com/4-aco-dmt/12
- Magic mushroom chocolates are having a moment. But do they even contain mushrooms?. Los Angeles Times (9 August 2024). https://www.latimes.com/california/story/2024-08-09/magic-mushroom-chocolates-are-having-a-moment-but-do-they-even-contain-mushrooms1234
- Mushroom edibles are rising in popularity. It's hard to say what's in them.. NBC News (18 July 2024). https://www.nbcnews.com/health/health-news/mushroom-edibles-are-rising-popularity-s-hard-say-s-rcna1624081
- Janikian, Michelle. (26 May 2020 (updated 11 July 2024)). The Complete Guide to 4-AcO-DMT: Synthetic Shrooms or in a Class of Its Own?. DoubleBlind Mag. https://doubleblindmag.com/4-aco-dmt-or-synthetic-shrooms/1
- Poisons Standard October 2015 (F2015L01534). Federal Register of Legislation, Australian Government / Therapeutic Goods Administration (2015-09-30). https://www.legislation.gov.au/F2015L01534/asmade/2015-09-30/text/original/pdf12
- NIH PubChem CID 15429212 compound properties (O-Acetylpsilocin). pubchem.ncbi.nlm.nih.gov (n.d.). https://pubchem.ncbi.nlm.nih.gov/rest/pug/compound/cid/15429212/property/IUPACName,Title,CanonicalSMILES,MolecularFormula/JSON1
- AFMPS Annex IV non-official consolidated reference, valid from 29 March 2026 (correction 16 July 2026). afmps.be (n.d.). https://www.afmps.be/sites/default/files/content/INSP/NARC/annex%20IV_non%20official%20consolidated%20version.pdf1
- Royal Decree of 6 September 2017, Belgian Official Journal original publication (Numac 2017031231). ejustice.just.fgov.be (n.d.). https://www.ejustice.just.fgov.be/cgi/article_body.pl?language=fr&caller=summary&pub_date=17-09-26&numac=20170312311
- Royal Decree of 6 September 2017 regulating narcotic and psychotropic substances, current consolidated text. ejustice.just.fgov.be (n.d.). https://www.ejustice.just.fgov.be/eli/arrete/2017/09/06/2017031231/justel1
- Royal Decree of 15 March 2026 amending the Royal Decree of 6 September 2017. ejustice.just.fgov.be (n.d.). https://www.ejustice.just.fgov.be/eli/arrete/2026/03/15/2026002219/justel1
- AFMPS Legislation — Substances. afmps.be (n.d.). https://www.afmps.be/fr/humain/produits_particuliers/subst_specialement_reglementees/stupefiants_et_psychotropes/substances1
- Portaria SVS/MS No. 344, de 12 de maio de 1998 (consolidated current text). anvisalegis.datalegis.net (n.d.). https://anvisalegis.datalegis.net/action/ActionDatalegis.php?acao=abrirTextoAto&tipo=POR&numeroAto=00000344&seqAto=000&valorAno=1998&orgao=SVS/MS&codTipo=&desItem=&desItemFim=&cod_menu=1696&cod_modulo=134&pesquisa=true1
- Lei No. 11.343, de 23 de agosto de 2006 (updated text). www2.camara.leg.br (n.d.). https://www2.camara.leg.br/legin/fed/lei/2006/lei-11343-23-agosto-2006-545399-normaatualizada-pl.html1
- Lista de substâncias sujeitas a controle especial no Brasil. gov.br (n.d.). https://www.gov.br/anvisa/pt-br/assuntos/medicamentos/controlados/lista-substancias1
- Nařízení vlády č. 463/2013 Sb., o seznamech návykových látek, current consolidated text effective 25 June 2026. e-sbirka.gov.cz (n.d.). https://e-sbirka.gov.cz/sb/2013/463/2026-06-251
- Zákon č. 167/1998 Sb., o návykových látkách, §§ 2(1)(a), 3(1)-(2), 4, current consolidated text effective 1 January 2026. e-sbirka.gov.cz (n.d.). https://e-sbirka.gov.cz/sb/1998/167/2026-01-011
- Nařízení vlády č. 242/2018 Sb., official promulgated amendment text. e-sbirka.gov.cz (n.d.). https://e-sbirka.gov.cz/sb/2018/242/0000-00-001
- Nařízení vlády č. 107/2026 Sb., official amendment text. e-sbirka.gov.cz (n.d.). https://e-sbirka.gov.cz/sb/2026/1071
- Neue-psychoaktive-Stoffe-Gesetz, Anlage. gesetze-im-internet.de (n.d.). https://www.gesetze-im-internet.de/npsg/anlage_1.html1
- NIH PubChem CID 15429212 synonym record (O-Acetylpsilocin). pubchem.ncbi.nlm.nih.gov (n.d.). https://pubchem.ncbi.nlm.nih.gov/rest/pug/compound/cid/15429212/synonyms/JSON1
- Dangerous Drugs Ordinance [New Version], 5733-1973, consolidated Hebrew text. chamber.org.il (n.d.). https://www.chamber.org.il/media/159581/samim_01.pdf1
- Dangerous Drugs Ordinance [New Version], 5733-1973, current consolidated Hebrew schedule text (First Schedule Part A Sign B item 6). he.wikisource.org (n.d.). https://he.wikisource.org/wiki/%D7%A4%D7%A7%D7%95%D7%93%D7%AA_%D7%94%D7%A1%D7%9E%D7%99%D7%9D_%D7%94%D7%9E%D7%A1%D7%95%D7%9B%D7%A0%D7%99%D7%9D1
- Notice of Dangerous Drugs (Amendment of the First Schedule), 5777-2017, Official Gazette (Kovetz HaTakanot 7775). olaw.org.il (n.d.). https://olaw.org.il/takanot/takanot-7775.pdf1
- Notice of Dangerous Drugs (Amendment of the First Schedule to the Ordinance), 5785-2025, Official Gazette (Kovetz HaTakanot 11879). new.isa.gov.il (n.d.). https://www.new.isa.gov.il/images/Fittings/isa/asset_library_pic/al_lobby/al_lobby-628ce07f9490d/takanot_2025.pdf1
- Decreto del Ministero della Salute, 6 agosto 2021 (aggiornamento Tabella I, DPR 9 ottobre 1990 n. 309). Ministero della Salute (Italy) (2021-08-06). https://www.medicoeleggi.com/argomenti000/italia2021/413541-1.htm1
- 危険ドラッグの成分４物質を新たに指定薬物に指定. (2022). https://www.mhlw.go.jp/stf/houdou/0000092698.html1
- Föreskrifter om ändring i Läkemedelsverkets föreskrifter (LVFS 2011:10) om förteckningar över narkotika. (n.d.). https://lakemedelsverket.se/upload/lvfs/HSLF-FS_2017_1.pdf1
- Verordnung des EDI über die Verzeichnisse der Betäubungsmittel, psychotropen Stoffe, Vorläuferstoffe und Hilfschemikalien (Betäubungsmittelverzeichnisverordnung, BetmVV-EDI, SR 812.121.11). Eidgenössisches Departement des Innern (EDI) / Fedlex (2011-05-30). https://www.fedlex.admin.ch/eli/cc/2011/363/de1
- Decision No. 2013/5742 annex list, Official Gazette No. 28893 (25 January 2014). resmigazete.gov.tr (n.d.). https://resmigazete.gov.tr/eskiler/2014/01/20140125-3-1.pdf1
- Bazı Maddelerin 2313 Sayılı Uyuşturucu Maddelerin Murakabesi Hakkında Kanun Hükümlerine Tabi Tutulması Hakkında Karar (Decision No. 2013/5742), Official Gazette No. 28893, decision page. resmigazete.gov.tr (n.d.). https://resmigazete.gov.tr/eskiler/2014/01/20140125-3.htm1
- Türkiye Uyuşturucu Raporu 2014, TUBİM/Emniyet Genel Müdürlüğü. narkotik.pol.tr (n.d.). https://www.narkotik.pol.tr/kurumlar/narkotik.pol.tr/Arsiv/TUBIM/Documents/TURKIYE%20UYUSTURUCU%20RAPORU%202014.pdf1
- Uyuşturucu Maddelerin Murakabesi Hakkında Kanun (Law No. 2313), current consolidated text. mevzuat.gov.tr (n.d.). https://www.mevzuat.gov.tr/anasayfa/MevzuatFihristDetayIframe?MevzuatTur=1&MevzuatNo=2313&MevzuatTertip=31
- Türkiye Uyuşturucu Raporu: Eğilimler ve Gelişmeler (2024), Narkotik Suçlarla Mücadele Başkanlığı. narkotik.pol.tr (n.d.). https://www.narkotik.pol.tr/kurumlar/icisleri.gov.tr/duyurular(1)/2024_uyus_raporu.pdf1
- Misuse of Drugs Act 1971, Schedule 2 Part I generic ester control. legislation.gov.uk (n.d.). https://www.legislation.gov.uk/ukpga/1971/38/schedule/21
- 21 CFR 1308.11 - Schedule I. Code of Federal Regulations, Title 21 (n.d.). https://www.ecfr.gov/current/title-21/chapter-II/part-1308/subject-group-ECFR3ac9a628f2b3a17/section-1308.111
- 21 U.S.C. § 813 - Treatment of controlled substance analogues. United States Code, Title 21 (1986). https://www.law.cornell.edu/uscode/text/21/8131
- Controlled Substances List (Adopted by Alabama State Board of Health, effective February 21, 2018). Alabama Department of Forensic Sciences (2018-02-21). https://adfs.alabama.gov/Content/pdfs/drug-chemistry/2018%20Controlled%20Substance%20List.pdf1
Further Reading
- Reviewed & approved
Reviewed, edited, and approved by subject-matter expert Lyrea.
Automated synthesisInformation aggregated and synthesized using an autonomous workflow built by Josie Kins.
Suggest an edit
Spotted a mistake, an outdated claim, or something missing from the 4-AcO-DMT article? Send the editors a private note. Feedback lands in a moderation queue and is never shown on the site.
Wish to give generalised feedback? You can do so here.
